Real-world results confirm the benefits of dosing ZOMETA® every 3 to 4 weeks in patients like Carlo14
- Using alternative dosing schedules significantly compromises the benefits of ZOMETA14
Rate of SREs by dosing regimen*
*There are limitations to the study because the results are from a retrospective claims
database analysis.
- Treatment with ZOMETA 4 mg every 3 to 4 weeks significantly reduced the rate of skeletal morbidity (measured as number of events per month) vs no treatment14
- No other dosing schedule is proven to protect patients from SREs2,11-13
Achieve maximum potential benefit—treat with ZOMETA 4 mg every 3 to 4 weeks
